Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology (Q38105137)

28 August 2017

title

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology (English)

1 reference

28 August 2017

0 references

0 references

Anna N Ilinskaya

1

1 reference

28 August 2017

Marina A Dobrovolskaia

series ordinal

2

1 reference

28 August 2017

publication date

1 May 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

8

1 reference

28 August 2017

issue

5

1 reference

28 August 2017

page(s)

773-784

1 reference

Electrical contacts to one- and two-dimensional nanomaterials

28 August 2017

cites work

1 reference

21 January 2018

Carbon-based electronics

1 reference

Emerging nanotechnology-based strategies for the identification of microbial pathogenesis

21 January 2018

1 reference

Detection of bacteria in suspension by using a superconducting quantum interference device

21 January 2018

1 reference

Antimicrobial effects of silver nanoparticles against bacterial cells adhered to stainless steel surfaces.

21 January 2018

1 reference

Enhanced antimicrobial activity of nisin-loaded liposomal nanoparticles against foodborne pathogens.

21 January 2018

1 reference

Nanomedicine(s) under the microscope

21 January 2018

1 reference

Immunological properties of engineered nanomaterials

21 January 2018

1 reference

Nanoparticles and the immune system

21 January 2018

1 reference

Interactions of nanomaterials with the immune system

21 January 2018

1 reference

Innate immunity and coagulation.

21 January 2018

1 reference

Thrombin-activatable fibrinolysis inhibitor is degraded by Salmonella enterica and Yersinia pestis.

21 January 2018

1 reference

Fibrin and fibrinolysis in infection and host defense

21 January 2018

1 reference

Disseminated intravascular coagulation in infectious disease

21 January 2018

1 reference

Fibrinogen as a key regulator of inflammation in disease

21 January 2018

1 reference

Cancer, thrombosis and heparin-induced thrombocytopenia

21 January 2018

1 reference

Overview of the postulated mechanisms linking cancer and thrombosis

21 January 2018

1 reference

Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation

21 January 2018

1 reference

Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited

21 January 2018

1 reference

Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries

21 January 2018

1 reference

Platelet mRNA: the meaning behind the message

21 January 2018

1 reference

Endothelial activation, dysfunction and permeability during severe infections

21 January 2018

1 reference

Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?

21 January 2018

1 reference

Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases

21 January 2018

1 reference

Mechanisms of thrombus formation

21 January 2018

1 reference

Remodeling the blood coagulation cascade

21 January 2018

1 reference

The growing complexity of platelet aggregation

21 January 2018

1 reference

Repeated oral administration of chitosan/DNA nanoparticles delivers functional FVIII with the absence of antibodies in hemophilia A mice

21 January 2018

1 reference

Costs of care in hemophilia and possible implications of health care reform

21 January 2018

1 reference

Intravenous hemostat: nanotechnology to halt bleeding.

21 January 2018

1 reference

Ligand binding to GPIIb-IIIa: a status report

21 January 2018

1 reference

Novel platelet substitutes: disk-shaped biodegradable nanosheets and their enhanced effects on platelet aggregation

21 January 2018

1 reference

Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system.

21 January 2018

1 reference

Management of acquired haemophilia A.

21 January 2018

1 reference

Synthesis and characterization of recombinant factor VIIa-conjugated magnetic iron oxide nanoparticles for hemophilia treatment

21 January 2018

1 reference

Recombinant factor VIIa: safety and efficacy

21 January 2018

1 reference

Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline

21 January 2018

1 reference

Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/II study.

21 January 2018

1 reference

Safety and efficacy of a long-acting liposomal formulation of plasma-derived factor VIII in haemophilia A patients.

21 January 2018

1 reference

Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment

21 January 2018

1 reference

Gene transfer to hemophilia A mice via oral delivery of FVIII-chitosan nanoparticles

21 January 2018

1 reference

Toward effective long-term prevention of thromboembolism: novel oral anticoagulant delivery systems

21 January 2018

1 reference

Heparin-based nanoparticles

21 January 2018

1 reference

Low molecular weight heparin gels, based on nanoparticles, for topical delivery

21 January 2018

1 reference

In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits

21 January 2018

1 reference

Regulation of thrombin activity--pharmacologic and structural aspects

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Anti-coagulant aptamers

1 reference

Highly efficient control of thrombin activity by multivalent nanoparticles

21 January 2018

1 reference

P2Y12 receptor in platelet activation

21 January 2018

1 reference

Functionalized congeners of P2Y1 receptor antagonists: 2-alkynyl (N)-methanocarba 2'-deoxyadenosine 3',5'-bisphosphate analogues and conjugation to a polyamidoamine (PAMAM) dendrimer carrier

21 January 2018

1 reference

Toward multivalent signaling across G protein-coupled receptors from poly(amidoamine) dendrimers

21 January 2018

1 reference

PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors

21 January 2018

1 reference

A(2A) adenosine receptors in human peripheral blood cells

21 January 2018

1 reference

Translational considerations for cancer nanomedicine

21 January 2018

1 reference

Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties

21 January 2018

1 reference

Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets

21 January 2018

1 reference

Second-generation perfluorocarbon emulsion blood substitutes

21 January 2018

1 reference

The antithrombotic and antimicrobial properties of PEG-protected silver nanoparticle coated surfaces.

21 January 2018

1 reference

Antistreptokinase antibodies: implications for thrombolysis in a region with endemic streptococcal infection

21 January 2018

1 reference

Distributed intraclot thrombolysis: mechanism of accelerated thrombolysis with encapsulated plasminogen activators

21 January 2018

1 reference

Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles

21 January 2018

1 reference

EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery

21 January 2018

1 reference

A tissue factor targeted nanomedical system for thrombi-specific drug delivery

21 January 2018

1 reference

Water-soluble Fe3O4 nanoparticles with high solubility for removal of heavy-metal ions from waste water

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/NNM.13.48

1 reference

28 August 2017

1 reference